[1] | Pirot, F, “Alpha-emitting nanoparticulates, the forgotten pollutant”, in From an Einstein Syndrome to the People, 2019, Editions universitaires européennes. |
|
[2] | Pirot, F. “The link between salt and neurological disorders -the mediation of alpha-emitting nanoparticulates as simple explanation”, Porto Biomedical Journal, 4 (6). pe 55. 2019. |
|
[3] | Pirot, F. 'Traumatic Brain Injury: a Case Report and Its Contribution to Understanding the Underlying Mechanisms - Alpha-Emitting Nanoparticulates Proven as Key.' American Journal of Medical Case Reports 8, no. 4 (2020): 100-102. |
|
[4] | Miller AC, Rivas R, Tesoro L, Kovalenko G, Kovaric N, Pavlovic P, Brenner D, “Radiation exposure from depleted uranium: The radiation bystander effect”, Toxicology and Applied Pharmacology, 331 (15). 135-141. Sept 2017. |
|
[5] | Molloy, C., Conroy, R. M., Cotter, D. R., & Cannon, M. (2011). Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies. Schizophrenia bulletin, 37(6), 1104-1110. |
|
[6] | Hart S, Fischer OM, Ullrich A. Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res. 2004; 64(6): 1943-1950. |
|
[7] | Khan, M. I., Sobocińska, A. A., Brodaczewska, K. K., Zielniok, K., Gajewska, M., Kieda, C., Czarnecka, A. M., & Szczylik, C, Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212-2 in renal cell carcinoma. BMC Cancer 18, 583 (2018). |
|
[8] | Galve-Roperh I, Chiurchiù V, Díaz-Alonso J, Bari M, Guzmán M, Maccarrone M. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. Prog Lipid Res. 2013; 52(4): 633-650. |
|
[9] | De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci U S A. 1998 Jul 7; 95(14): 8375-80. |
|
[10] | Hagihara, H., Catts, V. S., Katayama, Y., Shoji, H., Takagi, T., Huang, F. L., Nakao, A., Mori, Y., Huang, K. P., Ishii, S., Graef, I. A., Nakayama, K. I., Shannon Weickert, C., & Miyakawa, T. (2018). Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 43(3), 459-468. |
|